Susanna A McColley

  • 5510 Citations
1991 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests

My clinical and research focus is cystic fibrosis. My research interests are developing new therapies, characterizing and treating early lung disease, and reducing outcomes disparities by identifying and treating children who are at higher risk for adverse outcomes. I am active in healthcare quality improvement at the practice and national level. Since newborn screening in cystic fibrosis has been established in the United States, I have been especially interested in refining care of the newly diagnosed infant and their family, and in bringing highly effective therapies into the care of infants. On the other end of the spectrum of pediatrics, I am engaged in research and program development in transition from pediatric to adult health care environments.

My major academic focus is therapeutic clinical trials. I also evaluate risk factors and health care system processes that contribute to disparate outcomes in cystic fibrosis. In my research leadership role, I enable trials in childhood-onset conditions.

I specialize in pediatric lung disease, focusing on diagnosis and treatment of children with cystic fibrosis.

Certifications and Licenses

Pediatric Pulmonology

Training Experience

1988Residency, Johns Hopkins Hospital
1991Fellowship, Johns Hopkins Hospital

Education/Academic qualification

MD, Northwestern University Feinberg School of Medicine

… → 1985

Research interests

  • Cystic Fibrosis
  • Health Disparities
  • Healthcare Quality
  • Pediatrics

Fingerprint Dive into the research topics where Susanna A McColley is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants

Research Output

Finding the relevance of antimicrobial stewardship for cystic fibrosis

Antimicrobial Resistance International Working Group in Cystic Fibrosis, Jan 1 2020, (Accepted/In press) In : Journal of Cystic Fibrosis.

Research output: Contribution to journalReview article

  • 1 Scopus citations
  • Cystic fibrosis year in review 2018, part 1

    Savant, A. P. & McColley, S. A., Aug 2019, In : Pediatric Pulmonology. 54, 8, p. 1117-1128 12 p.

    Research output: Contribution to journalReview article

  • 1 Scopus citations

    Cystic fibrosis year in review 2018, part 2

    Savant, A. P. & McColley, S. A., Aug 2019, In : Pediatric Pulmonology. 54, 8, p. 1129-1140 12 p.

    Research output: Contribution to journalReview article

  • Identification of molecular signatures of cystic fibrosis disease status with plasma-based functional genomics

    Levy, H., Jia, S., Pan, A., Zhang, X., Kaldunski, M., Nugent, M. L., Reske, M., Feliciano, R. A., Quintero, D., Renda, M. M., Woods, K. J., Murkowski, K., Johnson, K., Verbsky, J., Dasu, T., Ideozu, J. E., McColley, S., Quasney, M. W., Dahmer, M. K., Avner, E. & 5 others, Farrell, P. M., Cannon, C. L., Jacob, H., Simpson, P. M. & Hessner, M. J., Jan 2019, In : Physiological genomics. 51, 1, p. 27-41 15 p.

    Research output: Contribution to journalArticle

  • 5 Scopus citations